Germans Trias i Pujol Hospital

germanstrias.org

Total trials

84

Active

9

Phase 3

9

Total enrollment

16,496

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 2 of 2 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
SSRI1
IPACK block with Bupivacaine 0.25% with adrenaline1

Next readouts

  • 2024-06-01
  • 2026-12-31

Top conditions

  • HIV Infections25
  • HIV6
  • Heart Failure2
  • Major Depressive Disorder2
  • Healthy Subjects2
  • Multiple Sclerosis2
  • Latent Tuberculosis Infection2
  • Tuberculosis2

Frequently asked questions about Germans Trias i Pujol Hospital

How many clinical trials does Germans Trias i Pujol Hospital have on ClinicalTrials.gov?
Germans Trias i Pujol Hospital is listed as the lead sponsor on 84 clinical trials in ClinicalTrials.gov, 9 of which are currently active (recruiting, enrolling, or ongoing).
How many of Germans Trias i Pujol Hospital's trials are in Phase 3?
9 of Germans Trias i Pujol Hospital's trials are in Phase 3, spread across 2 active drug programs.
What therapeutic areas does Germans Trias i Pujol Hospital focus on?
Germans Trias i Pujol Hospital's most-studied conditions on ClinicalTrials.gov are HIV Infections, HIV, Heart Failure, Major Depressive Disorder, Healthy Subjects.
When are Germans Trias i Pujol Hospital's next clinical trial readouts?
Germans Trias i Pujol Hospital has 2 upcoming primary-completion readouts tracked here; the soonest is “Comparison of the Analgesic Effect of Subsartorial Saphenous Block and Popliteal Sciatic vs Subsartorial Saphenous Block and IPACK in Total Knee Replacement Surgery.”, expected around 2024-06-01.